MedPath

The study on metabolic and inflammatory biomarkers and gut microbiota in overweight Thai adults

Conditions
to investigate and compare the metabolic, inflammatory biomarkers and gut microbiota composition of normal and overweight in a nationally representative sample of Thai adults. Then, associations between will be analysed gut microbial concentrations, clinical-biochemical blood parameters and dietary patterns will be assessed.
Overweight, metabolic biomarkers, inflammatory biomarkers, gut microbiota, dietary pattern
Registration Number
TCTR20220204007
Lead Sponsor
Fundamental fund Kasetsart University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
60
Inclusion Criteria

Overweight (BMI more than or equal to 23 kg/m2)
Normal weight ((BMI 18.5 to 22.9 kg/m2)
20 years to 50 years of age

Exclusion Criteria

Any chronic disease
Medication for dyslipidemia, type 2 diabetes or elevated blood pressure
History of intestinal surgery
Pregnancy/breastfeeding
The use of antibiotics, pro-prebiotics within 3 months

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The comparison of metabolic biomarkers, inflammatory biomarkers and the gut microbiota composition 2 weeks after the first vist The gut microbiota will be analyzed by 16s amplicon sequencing technique, and metabolic parameters will be analyzed by blood chemistry analyzers
Secondary Outcome Measures
NameTimeMethod
The relationship between metabolic parameters and the gut microbiota composition and dietary pattern within one year after end of the intervention A multivariate linear regression analysis was performed in order to test associations between the gut microbiota composition and metabolic variables and diet pattern of participants
© Copyright 2025. All Rights Reserved by MedPath